OR2B2

Across TCGA pan-cancer cohorts, OR2B2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR2B2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR2B2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR2B2 is over-expressed in tumor.

BRCA, UCEC, and LIHC are the cancer types where OR2B2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR2B2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.080	.001	6	view →
UCEC	All	IV	+0.125	.037	2	view →
LIHC	All	All	+0.005	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR2B2–BRCA

Open the BRCA breakdown →